RSLAX | SCWFX | RSLAX / SCWFX | |
Total Expense Ratio | 1.74 | 1.08 | 161% |
Annual Report Gross Expense Ratio | 1.74 | 1.08 | 161% |
Fund Existence | 23 years | 24 years | - |
Gain YTD | 9.178 | 9.634 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 80.3B | 80.3B | 100% |
Annual Yield % from dividends | 0.11 | 0.55 | 20% |
Returns for 1 year | 9.47 | 10.19 | 93% |
Returns for 3 years | 19.14 | 21.55 | 89% |
Returns for 5 years | 9.35 | 14.88 | 63% |
Returns for 10 years | 35.72 | 50.46 | 71% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 67.81 | 0.63 | +0.93% |
Invesco Biotechnology & Genome ETF | |||
BBBI | 51.65 | -0.01 | -0.03% |
BondBloxx BBB Rated 5-10 Yr Corp Bd ETF | |||
FGD | 28.91 | -0.02 | -0.07% |
First Trust Dow Jones Global Sel Div ETF | |||
ITOT | 140.57 | -0.33 | -0.23% |
iShares Core S&P Total US Stock Mkt ETF | |||
STXM | 27.16 | -0.08 | -0.30% |
Strive Mid-Cap ETF |